A Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Multivalent Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Infants (C1091009)

Principal Investigator

Prof Manu Vatish

Contact us

Email: osprea@wrh.ox.ac.uk

IRAS number

1012260